MADIA Tech Launch - Fulgent Therapeutics road to Public Company

Actions and Detail Panel


Event Information

Share this event

Date and time



Online event

Event description
The Bumpy Road from Founding to being Publicly Traded Fulgent Therapeutics clinical genetic testing pioneer

About this event

MADIA Tech Launch


Founding to being Publicly Trading

Fulgent Therapeutics and Fulgent Genetics

Joe Roach, Co-Founder (Retired)

Wednesday, May 12

6:30 pm Zoom opens, Networking & Introductions

7:00 pm Presentation

7:45 pm Q & A

Learn, Enjoy, Engage.

Log-in and hear how Joe Roach guided Fulgent Genetics from founding through becoming the rapidly growing publicly traded clinical genetic testing company it is today.

Joe will discuss “Genesis through Publicly Traded Company and the Bumps and Bruises Along the Way.” (Check out Fulgent @ Fulgent is a rapidly growing, publicly traded NASDAQ company founded in 2011. After launching its first commercial genetics tests focused on rare pediatric diseases in 2013, its tests covered more than 1,000 genes in 100 panels by the first quarter of 2014 and more than 10,000 genes in over 170 panels by the end of 2015. Today, Fulgent has further expanded its test menu to offer more than 18,000 single-gene tests and more than 200 panels that collectively test for more than 7,500 genetic conditions, including various cancers, cardiovascular diseases and neurological disorders. Presentation starts at 7:00 p.m. and is preceded by virtual networking at 6:30.

Invite your friends and check out the entrepreneurial scene at the heart of San Gabriel Valley.

Virtual networking begins at 6:30. Presentation starts at 7:00 p.m. Hangout on Zoom after the presentation to continue sharing ideas, networking, and enjoying your favorite beverage.

Zoom link will be sent prior to meeting

		MADIA Tech Launch - Fulgent Therapeutics road to Public Company image
Share with friends

Date and time


Online event

Save This Event

Event Saved